These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28664714)

  • 1. Analysis of Acinetobacter baumannii resistance patterns in patients with chronic obstructive pulmonary disease (COPD) in terms of choice of effective empiric antibiotic therapy.
    Grochowalska A; Kozioł-Montewka M; Sobieszczańska A
    Ann Agric Environ Med; 2017 Jun; 24(2):307-311. PubMed ID: 28664714
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014-2015.
    Ziółkowski G; Pawłowska I; Krawczyk L; Wojkowska-Mach J
    J Infect Public Health; 2018; 11(5):626-630. PubMed ID: 29548877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.
    Guner R; Hasanoglu I; Keske S; Kalem AK; Tasyaran MA
    Infection; 2011 Dec; 39(6):515-8. PubMed ID: 21789524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):45-53. PubMed ID: 22808729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].
    Direkel Ş; Çopur Çiçek A; Karagöz A; Aydoğan Ejder N; Oktay E; Delialioğlu N; Özgümüş OB; Durmaz R
    Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle?
    Protic D; Pejovic A; Andjelkovic D; Djukanovic N; Savic D; Piperac P; Markovic Denic L; Zdravkovic M; Todorovic Z
    Surg Infect (Larchmt); 2016 Apr; 17(2):236-42. PubMed ID: 26885722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
    Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.